These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9317105

  • 1. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways.
    Daikh DI, Finck BK, Linsley PS, Hollenbaugh D, Wofsy D.
    J Immunol; 1997 Oct 01; 159(7):3104-8. PubMed ID: 9317105
    [Abstract] [Full Text] [Related]

  • 2. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
    Via CS, Rus V, Nguyen P, Linsley P, Gause WC.
    J Immunol; 1996 Nov 01; 157(9):4258-67. PubMed ID: 8892665
    [Abstract] [Full Text] [Related]

  • 3. Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand.
    Tang A, Judge TA, Nickoloff BJ, Turka LA.
    J Immunol; 1996 Jul 01; 157(1):117-25. PubMed ID: 8683104
    [Abstract] [Full Text] [Related]

  • 4. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.
    Saito K, Sakurai J, Ohata J, Kohsaka T, Hashimoto H, Okumura K, Abe R, Azuma M.
    J Immunol; 1998 May 01; 160(9):4225-31. PubMed ID: 9574523
    [Abstract] [Full Text] [Related]

  • 5. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.
    Mohan C, Shi Y, Laman JD, Datta SK.
    J Immunol; 1995 Feb 01; 154(3):1470-80. PubMed ID: 7529804
    [Abstract] [Full Text] [Related]

  • 6. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
    Tellander AC, Pettersson U, Runström A, Andersson M, Michaëlsson E.
    J Autoimmun; 2001 Aug 01; 17(1):39-50. PubMed ID: 11488636
    [Abstract] [Full Text] [Related]

  • 7. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses.
    Roy M, Aruffo A, Ledbetter J, Linsley P, Kehry M, Noelle R.
    Eur J Immunol; 1995 Feb 01; 25(2):596-603. PubMed ID: 7533092
    [Abstract] [Full Text] [Related]

  • 8. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
    Judge TA, Wu Z, Zheng XG, Sharpe AH, Sayegh MH, Turka LA.
    J Immunol; 1999 Feb 15; 162(4):1947-51. PubMed ID: 9973463
    [Abstract] [Full Text] [Related]

  • 9. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.
    Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC.
    Nature; 1996 May 30; 381(6581):434-8. PubMed ID: 8632801
    [Abstract] [Full Text] [Related]

  • 10. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
    Zheng XX, Markees TG, Hancock WW, Li Y, Greiner DL, Li XC, Mordes JP, Sayegh MH, Rossini AA, Strom TB.
    J Immunol; 1999 Apr 15; 162(8):4983-90. PubMed ID: 10202046
    [Abstract] [Full Text] [Related]

  • 11. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule.
    Nakajima A, Azuma M, Kodera S, Nuriya S, Terashi A, Abe M, Hirose S, Shirai T, Yagita H, Okumura K.
    Eur J Immunol; 1995 Nov 15; 25(11):3060-9. PubMed ID: 7489744
    [Abstract] [Full Text] [Related]

  • 12. Costimulation and its role in organ transplantation.
    Bluestone JA.
    Clin Transplant; 1996 Feb 15; 10(1 Pt 2):104-9. PubMed ID: 8680045
    [Abstract] [Full Text] [Related]

  • 13. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.
    Konieczny BT, Dai Z, Elwood ET, Saleem S, Linsley PS, Baddoura FK, Larsen CP, Pearson TC, Lakkis FG.
    J Immunol; 1998 Mar 01; 160(5):2059-64. PubMed ID: 9498741
    [Abstract] [Full Text] [Related]

  • 14. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Sharpe AH, Vallera DA.
    J Immunol; 1999 Jun 01; 162(11):6368-77. PubMed ID: 10352249
    [Abstract] [Full Text] [Related]

  • 15. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
    Gao D, Li J, Orosz CG, Bumgardner GL.
    Hepatology; 2000 Nov 01; 32(5):1018-28. PubMed ID: 11050052
    [Abstract] [Full Text] [Related]

  • 16. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4.
    Lakkis FG, Konieczny BT, Saleem S, Baddoura FK, Linsley PS, Alexander DZ, Lowry RP, Pearson TC, Larsen CP.
    J Immunol; 1997 Mar 01; 158(5):2443-8. PubMed ID: 9036995
    [Abstract] [Full Text] [Related]

  • 17. The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor.
    Freeman GJ, Cardoso AA, Boussiotis VA, Anumanthan A, Groves RW, Kupper TS, Clark EA, Nadler LM.
    J Immunol; 1998 Sep 15; 161(6):2708-15. PubMed ID: 9743327
    [Abstract] [Full Text] [Related]

  • 18. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X, Constant S, Jorritsma P, Bottomly K.
    J Immunol; 1997 Dec 15; 159(12):5956-63. PubMed ID: 9550393
    [Abstract] [Full Text] [Related]

  • 19. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
    Bolling SF, Lin H, Wei RQ, Turka LA.
    J Heart Lung Transplant; 1996 Sep 15; 15(9):928-35. PubMed ID: 8889989
    [Abstract] [Full Text] [Related]

  • 20. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection.
    Elloso MM, Scott P.
    J Immunol; 1999 Jun 01; 162(11):6708-15. PubMed ID: 10352289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.